What is Etiometry?
Founded in 2010 and headquartered in Massachusetts, Etiometry specializes in advanced clinical decision-support software. Its platform is engineered to empower clinicians in intensive care units (ICUs) by providing data-driven insights for patient care and treatment decisions. The company's focus on leveraging technology to enhance critical care outcomes positions it as a key player in the health-tech sector. Etiometry's enterprise-level funding suggests a mature stage of development, focused on scaling operations and expanding market reach.
How much funding has Etiometry raised?
Etiometry has raised a total of $9.3M across 2 funding rounds:
Debt
$350K
Series A
$9M
Debt (2020): $350K with participation from PPP
Series A (2021): $9M led by SKK 9i Ventures and Shamrock Holdings
Key Investors in Etiometry
Shamrock Holdings
Shamrock Holdings is an investment firm with a history of supporting established entities, likely bringing strategic guidance and financial stability to Etiometry's growth phase.
SKK 9i Ventures
SKK 9i Ventures, an undisclosed entity, participated in this funding round, suggesting a strategic interest in Etiometry's technology and market potential.
PPP
Public-Private Partnership
What's next for Etiometry?
With its recent major strategic investment, Etiometry is poised for accelerated growth and further development of its clinical decision-support solutions. The company's ability to attract significant capital indicates strong market validation and potential for broader adoption within healthcare systems. Future initiatives are likely to focus on enhancing platform capabilities, expanding its user base, and solidifying its position as a leader in data-driven critical care. This strategic financing will enable Etiometry to further its mission of improving patient outcomes through advanced technology.
See full Etiometry company page
